Hematology-Oncology
Targeting IL-6 Receptor Signaling Enhances Cytolytic CD4+ T Cells and Improves Outcomes After Cellular Immunotherapy
IL-6 receptor inhibition during hematopoietic stem cell transplantation fosters type I interferon responses and promotes expansion of cytolytic CD4+ T cells, including Eomes+ subsets, augmenting antitumor immunity while mitigating graft-ver